ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P46531


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name NOTC1_HUMAN
Primary accession number P46531
Secondary accession numbers Q59ED8 Q5SXM3
Integrated into Swiss-Prot on November 1, 1995
Sequence was last modified on September 23, 2008 (Sequence version 4)
Annotations were last modified on    June 16, 2009 (Entry version 117)
Name and origin of the protein
Protein name Neurogenic locus notch homolog protein 1 [Precursor]
Synonyms Notch 1
hN1
Translocation-associated notch protein TAN-1
Contains Notch 1 extracellular truncation
Notch 1 intracellular domain
Gene name
Name: NOTCH1
Synonyms: TAN1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Brain;
Mann R.S., Blaumueller C.M., Zagouras P.;
"Complete human notch 1 (hN1) cDNA sequence.";
Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature02465; PubMed=15164053 [NCBI, ExPASy, EBI, Israel, Japan]
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
[3]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-2443.
DOI=10.1016/0092-8674(91)90111-B; PubMed=1831692 [NCBI, ExPASy, EBI, Israel, Japan]
Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., Sklar J.;
"TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.";
Cell 66:649-661(1991).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 489-2555.
TISSUE=Aortic endothelium;
Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F.;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
[5]
IDENTIFICATION OF LIGANDS.
PubMed=10079256 [NCBI, ExPASy, EBI, Israel, Japan]
Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.-L., Banks A., Leiman J., Ward D., Ish-Horowitz D., Artavanis-Tsakonas S.;
"Human ligands of the Notch receptor.";
Am. J. Pathol. 154:785-794(1999).
[6]
INTERACTION WITH DTX1.
DOI=10.1038/ng0598-74; PubMed=9590294 [NCBI, ExPASy, EBI, Israel, Japan]
Matsuno K., Eastman D., Mitsiades T., Quinn A.M., Carcanciu M.L., Ordentlich P., Kadesch T., Artavanis-Tsakonas S.;
"Human deltex is a conserved regulator of Notch signalling.";
Nat. Genet. 19:74-78(1998).
[7]
INTERACTION WITH MAML1.
DOI=10.1038/82644; PubMed=11101851 [NCBI, ExPASy, EBI, Israel, Japan]
Wu L., Aster J.C., Blacklow S.C., Lake R., Artavanis-Tsakonas S., Griffin J.D.;
"MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors.";
Nat. Genet. 26:484-489(2000).
[8]
INTERACTION WITH MAML2 AND MAML3.
DOI=10.1128/MCB.22.21.7688-7700.2002; PubMed=12370315 [NCBI, ExPASy, EBI, Israel, Japan]
Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D.;
"Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.";
Mol. Cell. Biol. 22:7688-7700(2002).
[9]
STRUCTURE BY NMR OF 1446-1480 IN COMPLEX WITH CALCIUM IONS, AND DISULFIDE BONDS.
DOI=10.1021/bi034156y; PubMed=12795601 [NCBI, ExPASy, EBI, Israel, Japan]
Vardar D., North C.L., Sanchez-Irizarry C., Aster J.C., Blacklow S.C.;
"Nuclear magnetic resonance structure of a prototype Lin12-Notch repeat module from human Notch1.";
Biochemistry 42:7061-7067(2003).
[10]
STRUCTURE BY NMR OF 411-526.
DOI=10.1016/j.str.2004.09.012; PubMed=15576031 [NCBI, ExPASy, EBI, Israel, Japan]
Hambleton S., Valeyev N.V., Muranyi A., Knott V., Werner J.M., McMichael A.J., Handford P.A., Downing A.K.;
"Structural and functional properties of the human notch-1 ligand binding region.";
Structure 12:2173-2183(2004).
[11]
X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1872-2114.
DOI=10.1042/BJ20050515; PubMed=16011479 [NCBI, ExPASy, EBI, Israel, Japan]
Ehebauer M.T., Chirgadze D.Y., Hayward P., Martinez Arias A., Blundell T.L.;
"High-resolution crystal structure of the human Notch 1 ankyrin domain.";
Biochem. J. 392:13-20(2005).
[12]
X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 1872-2126 IN COMPLEX WITH RBPSUH AND MAML1.
DOI=10.1016/j.cell.2005.12.037; PubMed=16530044 [NCBI, ExPASy, EBI, Israel, Japan]
Nam Y., Sliz P., Song L., Aster J.C., Blacklow S.C.;
"Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes.";
Cell 124:973-983(2006).
[13]
INVOLVEMENT IN AORTIC VALVE DISEASE.
DOI=10.1038/nature03940; PubMed=16025100 [NCBI, ExPASy, EBI, Israel, Japan]
Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D.;
"Mutations in NOTCH1 cause aortic valve disease.";
Nature 437:270-274(2005).
Comments
  • FUNCTION: Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBP-J kappa and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. May be important for normal lymphocyte function. In altered form, may contribute to transformation or progression in some T-cell neoplasms. Involved in the maturation of both CD4+ and CD8+ cells in the thymus. May be important for follicular differentiation and possibly cell fate selection within the follicle. During cerebellar development, may function as a receptor for neuronal DNER and may be involved in the differentiation of Bergmann glia (By similarity).
  • SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and an N-terminal fragment N(EC) which are probably linked by disulfide bonds. Interacts with DNER, DTX1, DTX2 and RBPSUH. Also interacts with MAML1, MAML2 and MAML3 which act as transcriptional coactivators for NOTCH1.
  • INTERACTION:
    Q06330:RBPJ; NbExp=1; IntAct=EBI-636374, EBI-632552;
    Q13573:SNW1; NbExp=2; IntAct=EBI-636374, EBI-632715;
  • SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein (By similarity).
  • SUBCELLULAR LOCATION: Notch 1 intracellular domain: Nucleus (By similarity). Note=Following proteolytical processing NICD is translocated to the nucleus (By similarity).
  • TISSUE SPECIFICITY: In fetal tissues most abundant in spleen, brain stem and lung. Also present in most adult tissues where it is found mainly in lymphoid tissues.
  • PTM: Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane (By similarity).
  • PTM: Phosphorylated (By similarity).
  • DISEASE: NOTCH1 truncation is associated with T-cell acute lymphoblastic leukemia.
  • DISEASE: Defects in NOTCH1 are a cause of aortic valve disease [MIM:109730]. The disorder consists of an early developmental defect in the aortic valve and a later de-repression of calcium deposition that causes progressive aortic valve disease. Calcification of the aortic valve is the third leading cause of heart disease in adults. The incidence increases with age, and it is often associated with a bicuspid aortic valve present in 1-2% of the population.
  • SIMILARITY: Belongs to the NOTCH family.
  • SIMILARITY: Contains 5 ANK repeats.
  • SIMILARITY: Contains 36 EGF-like domains.
  • SIMILARITY: Contains 3 LNR (Lin/Notch) repeats.
  • WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/NOTCH1ID30ch9q34.html";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AF308602; AAG33848.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL592301; CAI13934.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL354671; CAI13934.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL354671; CAI16149.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL592301; CAI16149.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M73980; AAA60614.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB209873; BAD93110.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00412982; -.
PIR A40043; A40043.
RefSeq NP_060087.3; -.
UniGene Hs.495473
3D structure databases
PDB
1PB5; NMR; -; A=1446-1480.[ExPASy / RCSB / EBI]
1TOZ; NMR; -; A=411-526.[ExPASy / RCSB / EBI]
1YYH; X-ray; 1.90 A; A/B=1872-2114.[ExPASy / RCSB / EBI]
2F8X; X-ray; 3.25 A; K=1872-2126.[ExPASy / RCSB / EBI]
2F8Y; X-ray; 1.55 A; A/B=1905-2126.[ExPASy / RCSB / EBI]
2HE0; X-ray; 1.90 A; A/B=1873-2114.[ExPASy / RCSB / EBI]
2VJ3; X-ray; 2.60 A; A=411-526.[ExPASy / RCSB / EBI]
3ETO; X-ray; 2.00 A; A/B=1447-1733.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1PB5; -.
1TOZ; -.
1YYH; -.
2F8X; -.
2F8Y; -.
2HE0; -.
2VJ3; -.
3ETO; -.
ModBase P46531.
Protein-protein interaction databases
IntAct P46531; 7.
PTM databases
PhosphoSite P46531; -.
Enzyme and pathway databases
Pathway_Interaction_DB ps1pathway; Presenilin action in Notch and Wnt signaling.
Reactome REACT_299; Signaling by Notch.
REACT_71; Gene Expression.
Organism-specific databases
GeneCards GC09M138508; -.
H-InvDB HIX0008549; -.
HGNC HGNC:7881; NOTCH1.
GenAtlas NOTCH1.
MIM 109730; phenotype. [NCBI / EBI]
190198; gene. [NCBI / EBI]
Orphanet 1244; Bicuspid aortic valve.
86871; Leukemia, T-cell prolymphocytic.
PharmGKB PA31683; -.
Gene expression databases
ArrayExpress P46531; -.
Bgee P46531; -.
CleanEx HS_NOTCH1; -.
GermOnline ENSG00000148400; Homo sapiens.
Ontologies
GO
GO:0016021; Cellular component: integral to membrane (non-traceable author statement from UniProtKB).
GO:0005634; Cellular component: nucleus (traceable author statement from UniProtKB).
GO:0005886; Cellular component: plasma membrane (inferred from electronic annotation from UniProtKB-SubCell).
GO:0005509; Molecular function: calcium ion binding (inferred from electronic annotation from UniProtKB-KW).
GO:0005515; Molecular function: protein binding (inferred from physical interaction from UniProtKB).
GO:0004872; Molecular function: receptor activity (inferred from electronic annotation from UniProtKB-KW).
GO:0006955; Biological process: immune response (non-traceable author statement from UniProtKB).
GO:0045662; Biological process: negative regulation of myoblast differentiation (inferred from mutant phenotype from UniProtKB).
GO:0007219; Biological process: Notch signaling pathway (traceable author statement from UniProtKB).
GO:0006350; Biological process: transcription (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR002110; ANK.
IPR006209; EGF.
IPR006210; EGF-like.
IPR013032; EGF-like_reg_CS.
IPR000152; EGF-type_Asp/Asn_hydroxyl_CS.
IPR000742; EGF_3.
IPR001881; EGF_Ca_bd.
IPR013091; EGF_Ca_bd_2.
IPR018097; EGF_Ca_bd_CS.
IPR010660; Notch_NOD.
IPR011656; Notch_NODP.
IPR000800; Notch_region.
Graphical view of domain structure.
Gene3D G3DSA:1.25.40.20; ANK; 1.
Pfam PF00023; Ank; 6.
PF00008; EGF; 30.
PF07645; EGF_CA; 4.
PF06816; NOD; 1.
PF07684; NODP; 1.
PF00066; Notch; 3.
Pfam graphical view of domain structure.
PRINTS PR01452; NOTCH.
SMART SM00248; ANK; 6.
SM00181; EGF; 11.
SM00179; EGF_CA; 24.
SM00004; NL; 3.
SMART graphical view of domain structure.
PROSITE PS50297; ANK_REP_REGION; 1.
PS50088; ANK_REPEAT; 4.
PS00010; ASX_HYDROXYL; 22.
PS00022; EGF_1; 35.
PS01186; EGF_2; 27.
PS50026; EGF_3; 36.
PS01187; EGF_CA; 20.
PS50258; LNR; 3.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE P46531; -.
Genome annotation databases
Ensembl ENSG00000148400; Homo sapiens. [Contig view]
GeneID 4851; -.
KEGG hsa:4851; -.
Phylogenomic databases
HOVERGEN P46531; -.
Other
NextBio 18684; -.
SOURCE NOTCH1; Homo sapiens.
ProtoNet P46531.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Activator; ANK repeat; Calcium; Cell membrane; Developmental protein; Differentiation; Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Metal-binding; Notch signaling pathway; Nucleus; Phosphoprotein; Polymorphism; Receptor; Repeat; Signal; Transcription; Transcription regulation; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
SIGNAL   1     18  18     Potential. 
CHAIN   19   2555  2537     Neurogenic locus notch homolog protein 1. PRO_0000007674
CHAIN   1721   2555  835     Notch 1 extracellular truncation (By similarity). PRO_0000007675
CHAIN   1754   2555  802     Notch 1 intracellular domain (By similarity). PRO_0000007676
TOPO_DOM   19   1735  1717     Extracellular (Potential). 
TRANSMEM   1736   1756  21     Potential. 
TOPO_DOM   1757   2555  799     Cytoplasmic (Potential). 
DOMAIN   20     58  39     EGF-like 1. 
DOMAIN   59     99  41     EGF-like 2. 
DOMAIN   102    139  38     EGF-like 3. 
DOMAIN   140    176  37     EGF-like 4. 
DOMAIN   178    216  39     EGF-like 5; calcium-binding (Potential). 
DOMAIN   218    255  38     EGF-like 6. 
DOMAIN   257    293  37     EGF-like 7; calcium-binding (Potential). 
DOMAIN   295    333  39     EGF-like 8; calcium-binding (Potential). 
DOMAIN   335    371  37     EGF-like 9; calcium-binding (Potential). 
DOMAIN   372    410  39     EGF-like 10. 
DOMAIN   412    450  39     EGF-like 11; calcium-binding (Potential). 
DOMAIN   452    488  37     EGF-like 12; calcium-binding (Potential). 
DOMAIN   490    526  37     EGF-like 13; calcium-binding (Potential). 
DOMAIN   528    564  37     EGF-like 14; calcium-binding (Potential). 
DOMAIN   566    601  36     EGF-like 15; calcium-binding (Potential). 
DOMAIN   603    639  37     EGF-like 16; calcium-binding (Potential). 
DOMAIN   641    676  36     EGF-like 17; calcium-binding (Potential). 
DOMAIN   678    714  37     EGF-like 18; calcium-binding (Potential). 
DOMAIN   716    751  36     EGF-like 19; calcium-binding (Potential). 
DOMAIN   753    789  37     EGF-like 20. 
DOMAIN   791    827  37     EGF-like 21; calcium-binding (Potential). 
DOMAIN   829    867  39     EGF-like 22. 
DOMAIN   869    905  37     EGF-like 23; calcium-binding (Potential). 
DOMAIN   907    943  37     EGF-like 24. 
DOMAIN   945    981  37     EGF-like 25; calcium-binding (Potential). 
DOMAIN   983   1019  37     EGF-like 26. 
DOMAIN   1021   1057  37     EGF-like 27. 
DOMAIN   1059   1095  37     EGF-like 28. 
DOMAIN   1097   1143  47     EGF-like 29. 
DOMAIN   1145   1181  37     EGF-like 30. 
DOMAIN   1183   1219  37     EGF-like 31; calcium-binding (Potential). 
DOMAIN   1221   1265  45     EGF-like 32; calcium-binding (Potential). 
DOMAIN   1267   1305  39     EGF-like 33. 
DOMAIN   1307   1346  40     EGF-like 34. 
DOMAIN   1348   1384  37     EGF-like 35. 
DOMAIN   1387   1426  40     EGF-like 36. 
REPEAT   1449   1489  41     LNR 1. 
REPEAT   1490   1531  42     LNR 2. 
REPEAT   1532   1571  40     LNR 3. 
REPEAT   1927   1956  30     ANK 1. 
REPEAT   1960   1990  31     ANK 2. 
REPEAT   1994   2023  30     ANK 3. 
REPEAT   2027   2056  30     ANK 4. 
REPEAT   2060   2089  30     ANK 5. 
COMPBIAS   1575   1578  4     Poly-Val. 
COMPBIAS   1661   1664  4     Poly-Arg. 
COMPBIAS   1728   1731  4     Poly-Pro. 
COMPBIAS   1740   1743  4     Poly-Ala. 
COMPBIAS   1901   1904  4     Poly-Glu. 
COMPBIAS   2259   2262  4     Poly-Gly. 
COMPBIAS   2403   2406  4     Poly-Gln. 
COMPBIAS   2410   2417  8     Poly-Pro. 
COMPBIAS   2521   2524  4     Poly-Ser. 
METAL   1457   1457        Calcium; via carbonyl oxygen. 
METAL   1460   1460        Calcium. 
METAL   1475   1475        Calcium. 
METAL   1478   1478        Calcium. 
SITE   1664   1665  2     Cleavage; by furin-like protease (By similarity). 
CARBOHYD   41     41        N-linked (GlcNAc...) (Potential). 
CARBOHYD   959    959        N-linked (GlcNAc...) (Potential). 
CARBOHYD   1179   1179        N-linked (GlcNAc...) (Potential). 
CARBOHYD   1241   1241        N-linked (GlcNAc...) (Potential). 
CARBOHYD   1489   1489        N-linked (GlcNAc...) (Potential). 
CARBOHYD   1587   1587        N-linked (GlcNAc...) (Potential). 
DISULFID   24     37        By similarity. 
DISULFID   31     46        By similarity. 
DISULFID   48     57        By similarity. 
DISULFID   63     74        By similarity. 
DISULFID   68     87        By similarity. 
DISULFID   89     98        By similarity. 
DISULFID   106    117        By similarity. 
DISULFID   111    127        By similarity. 
DISULFID   129    138        By similarity. 
DISULFID   144    155        By similarity. 
DISULFID   149    164        By similarity. 
DISULFID   166    175        By similarity. 
DISULFID   182    195        By similarity. 
DISULFID   189    204        By similarity. 
DISULFID   206    215        By similarity. 
DISULFID   222    233        By similarity. 
DISULFID   227    243        By similarity. 
DISULFID   245    254        By similarity. 
DISULFID   261    272        By similarity. 
DISULFID   266    281        By similarity. 
DISULFID   283    292        By similarity. 
DISULFID   299    312        By similarity. 
DISULFID   306    321        By similarity. 
DISULFID   323    332        By similarity. 
DISULFID   339    350        By similarity. 
DISULFID   344    359        By similarity. 
DISULFID   361    370        By similarity. 
DISULFID   376    387        By similarity. 
DISULFID   381    398        By similarity. 
DISULFID   400    409        By similarity. 
DISULFID   416    429        By similarity. 
DISULFID   423    438        By similarity. 
DISULFID   440    449        By similarity. 
DISULFID   456    467        By similarity. 
DISULFID   461    476        By similarity. 
DISULFID   478    487        By similarity. 
DISULFID   494    505        By similarity. 
DISULFID   499    514        By similarity. 
DISULFID   516    525        By similarity. 
DISULFID   532    543        By similarity. 
DISULFID   537    552        By similarity. 
DISULFID   554    563        By similarity. 
DISULFID   570    580        By similarity. 
DISULFID   575    589        By similarity. 
DISULFID   591    600        By similarity. 
DISULFID   607    618        By similarity. 
DISULFID   612    627        By similarity. 
DISULFID   629    638        By similarity. 
DISULFID   645    655        By similarity. 
DISULFID   650    664        By similarity. 
DISULFID   666    675        By similarity. 
DISULFID   682    693        By similarity. 
DISULFID   687    702        By similarity. 
DISULFID   704    713        By similarity. 
DISULFID   720    730        By similarity. 
DISULFID   725    739        By similarity. 
DISULFID   741    750        By similarity. 
DISULFID   757    768        By similarity. 
DISULFID   762    777        By similarity. 
DISULFID   779    788        By similarity. 
DISULFID   795    806        By similarity. 
DISULFID   800    815        By similarity. 
DISULFID   817    826        By similarity. 
DISULFID   833    844        By similarity. 
DISULFID   838    855        By similarity. 
DISULFID   857    866        By similarity. 
DISULFID   873    884        By similarity. 
DISULFID   878    893        By similarity. 
DISULFID   895    904        By similarity. 
DISULFID   911    922        By similarity. 
DISULFID   916    931        By similarity. 
DISULFID   933    942        By similarity. 
DISULFID   949    960        By similarity. 
DISULFID   954    969        By similarity. 
DISULFID   971    980        By similarity. 
DISULFID   987    998        By similarity. 
DISULFID   992   1007        By similarity. 
DISULFID   1009   1018        By similarity. 
DISULFID   1025   1036        By similarity. 
DISULFID   1030   1045        By similarity. 
DISULFID   1047   1056        By similarity. 
DISULFID   1063   1074        By similarity. 
DISULFID   1068   1083        By similarity. 
DISULFID   1085   1094        By similarity. 
DISULFID   1101   1122        By similarity. 
DISULFID   1116   1131        By similarity. 
DISULFID   1133   1142        By similarity. 
DISULFID   1149   1160        By similarity. 
DISULFID   1154   1169        By similarity. 
DISULFID   1171   1180        By similarity. 
DISULFID   1187   1198        By similarity. 
DISULFID   1192   1207        By similarity. 
DISULFID   1209   1218        By similarity. 
DISULFID   1225   1244        By similarity. 
DISULFID   1238   1253        By similarity. 
DISULFID   1255   1264        By similarity. 
DISULFID   1271   1284        By similarity. 
DISULFID   1276   1293        By similarity. 
DISULFID   1295   1304        By similarity. 
DISULFID   1311   1322        By similarity. 
DISULFID   1316   1334        By similarity. 
DISULFID   1336   1345        By similarity. 
DISULFID   1352   1363        By similarity. 
DISULFID   1357   1372        By similarity. 
DISULFID   1374   1383        By similarity. 
DISULFID   1391   1403        By similarity. 
DISULFID   1397   1414        By similarity. 
DISULFID   1416   1425        By similarity. 
DISULFID   1449   1472         
DISULFID   1454   1467         
DISULFID   1463   1479         
DISULFID   1490   1514        By similarity. 
DISULFID   1496   1509        By similarity. 
DISULFID   1505   1521        By similarity. 
DISULFID   1536   1549        By similarity. 
DISULFID   1545   1561        By similarity. 
VARIANT   300    300  1     Q -> R (in dbSNP:rs11574885 [NCBI]). VAR_034898 
VARIANT   879    879  1     R -> W (in dbSNP:rs11574895 [NCBI]). VAR_048990 
VARIANT   1671   1671  1     V -> I (in dbSNP:rs2229968 [NCBI]). VAR_046618 
CONFLICT   187    187        G -> R (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   282    282        R -> P (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   477    477        I -> M (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   614    615        HG -> LR (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   621    621        R -> P (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   677    677        I -> S (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   775    775        Y -> I (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   803    803        Q -> K (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   860    862        GWQ -> AGAK (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   1021   1021        D -> V (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   1028   1028        Q -> R (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   1032   1032        H -> L (in Ref. 1; AAG33848 and 3; AAA60614). 
CONFLICT   1040   1043        CGSY -> RGLH (in Ref. 1; AAG33848 and 3; AAA60614). 
HELIX   415    418  4      
STRAND   426    431  6      
STRAND   433    440  8      
STRAND   445    449  5      
TURN   455    458  4      
STRAND   462    470  9      
STRAND   473    477  5      
TURN   484    487  4      
HELIX   494    496  3      
STRAND   504    507  4      
STRAND   509    515  7      
HELIX   1931   1937  7      
HELIX   1941   1949  9      
HELIX   1964   1971  8      
HELIX   1974   1982  9      
HELIX   1998   2005  8      
HELIX   2010   2016  7      
HELIX   2031   2038  8      
HELIX   2041   2049  9      
HELIX   2064   2071  8      
HELIX   2074   2082  9      
HELIX   2097   2103  7      
HELIX   2107   2114  8      
Sequence information
Length: 2555 AA [This is the length of the unprocessed precursor] Molecular weight: 272505 Da [This is the MW of the unprocessed precursor] CRC64: E173C872D195F028 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MPPLLAPLLC LALLPALAAR GPRCSQPGET CLNGGKCEAA NGTEACVCGG AFVGPRCQDP 

        70         80         90        100        110        120 
NPCLSTPCKN AGTCHVVDRR GVADYACSCA LGFSGPLCLT PLDNACLTNP CRNGGTCDLL 

       130        140        150        160        170        180 
TLTEYKCRCP PGWSGKSCQQ ADPCASNPCA NGGQCLPFEA SYICHCPPSF HGPTCRQDVN 

       190        200        210        220        230        240 
ECGQKPGLCR HGGTCHNEVG SYRCVCRATH TGPNCERPYV PCSPSPCQNG GTCRPTGDVT 

       250        260        270        280        290        300 
HECACLPGFT GQNCEENIDD CPGNNCKNGG ACVDGVNTYN CRCPPEWTGQ YCTEDVDECQ 

       310        320        330        340        350        360 
LMPNACQNGG TCHNTHGGYN CVCVNGWTGE DCSENIDDCA SAACFHGATC HDRVASFYCE 

       370        380        390        400        410        420 
CPHGRTGLLC HLNDACISNP CNEGSNCDTN PVNGKAICTC PSGYTGPACS QDVDECSLGA 

       430        440        450        460        470        480 
NPCEHAGKCI NTLGSFECQC LQGYTGPRCE IDVNECVSNP CQNDATCLDQ IGEFQCICMP 

       490        500        510        520        530        540 
GYEGVHCEVN TDECASSPCL HNGRCLDKIN EFQCECPTGF TGHLCQYDVD ECASTPCKNG 

       550        560        570        580        590        600 
AKCLDGPNTY TCVCTEGYTG THCEVDIDEC DPDPCHYGSC KDGVATFTCL CRPGYTGHHC 

       610        620        630        640        650        660 
ETNINECSSQ PCRHGGTCQD RDNAYLCFCL KGTTGPNCEI NLDDCASSPC DSGTCLDKID 

       670        680        690        700        710        720 
GYECACEPGY TGSMCNINID ECAGNPCHNG GTCEDGINGF TCRCPEGYHD PTCLSEVNEC 

       730        740        750        760        770        780 
NSNPCVHGAC RDSLNGYKCD CDPGWSGTNC DINNNECESN PCVNGGTCKD MTSGYVCTCR 

       790        800        810        820        830        840 
EGFSGPNCQT NINECASNPC LNQGTCIDDV AGYKCNCLLP YTGATCEVVL APCAPSPCRN 

       850        860        870        880        890        900 
GGECRQSEDY ESFSCVCPTG WQGQTCEVDI NECVLSPCRH GASCQNTHGG YRCHCQAGYS 

       910        920        930        940        950        960 
GRNCETDIDD CRPNPCHNGG SCTDGINTAF CDCLPGFRGT FCEEDINECA SDPCRNGANC 

       970        980        990       1000       1010       1020 
TDCVDSYTCT CPAGFSGIHC ENNTPDCTES SCFNGGTCVD GINSFTCLCP PGFTGSYCQH 

      1030       1040       1050       1060       1070       1080 
DVNECDSQPC LHGGTCQDGC GSYRCTCPQG YTGPNCQNLV HWCDSSPCKN GGKCWQTHTQ 

      1090       1100       1110       1120       1130       1140 
YRCECPSGWT GLYCDVPSVS CEVAAQRQGV DVARLCQHGG LCVDAGNTHH CRCQAGYTGS 

      1150       1160       1170       1180       1190       1200 
YCEDLVDECS PSPCQNGATC TDYLGGYSCK CVAGYHGVNC SEEIDECLSH PCQNGGTCLD 

      1210       1220       1230       1240       1250       1260 
LPNTYKCSCP RGTQGVHCEI NVDDCNPPVD PVSRSPKCFN NGTCVDQVGG YSCTCPPGFV 

      1270       1280       1290       1300       1310       1320 
GERCEGDVNE CLSNPCDARG TQNCVQRVND FHCECRAGHT GRRCESVING CKGKPCKNGG 

      1330       1340       1350       1360       1370       1380 
TCAVASNTAR GFICKCPAGF EGATCENDAR TCGSLRCLNG GTCISGPRSP TCLCLGPFTG 

      1390       1400       1410       1420       1430       1440 
PECQFPASSP CLGGNPCYNQ GTCEPTSESP FYRCLCPAKF NGLLCHILDY SFGGGAGRDI 

      1450       1460       1470       1480       1490       1500 
PPPLIEEACE LPECQEDAGN KVCSLQCNNH ACGWDGGDCS LNFNDPWKNC TQSLQCWKYF 

      1510       1520       1530       1540       1550       1560 
SDGHCDSQCN SAGCLFDGFD CQRAEGQCNP LYDQYCKDHF SDGHCDQGCN SAECEWDGLD 

      1570       1580       1590       1600       1610       1620 
CAEHVPERLA AGTLVVVVLM PPEQLRNSSF HFLRELSRVL HTNVVFKRDA HGQQMIFPYY 

      1630       1640       1650       1660       1670       1680 
GREEELRKHP IKRAAEGWAA PDALLGQVKA SLLPGGSEGG RRRRELDPMD VRGSIVYLEI 

      1690       1700       1710       1720       1730       1740 
DNRQCVQASS QCFQSATDVA AFLGALASLG SLNIPYKIEA VQSETVEPPP PAQLHFMYVA 

      1750       1760       1770       1780       1790       1800 
AAAFVLLFFV GCGVLLSRKR RRQHGQLWFP EGFKVSEASK KKRREPLGED SVGLKPLKNA 

      1810       1820       1830       1840       1850       1860 
SDGALMDDNQ NEWGDEDLET KKFRFEEPVV LPDLDDQTDH RQWTQQHLDA ADLRMSAMAP 

      1870       1880       1890       1900       1910       1920 
TPPQGEVDAD CMDVNVRGPD GFTPLMIASC SGGGLETGNS EEEEDAPAVI SDFIYQGASL 

      1930       1940       1950       1960       1970       1980 
HNQTDRTGET ALHLAARYSR SDAAKRLLEA SADANIQDNM GRTPLHAAVS ADAQGVFQIL 

      1990       2000       2010       2020       2030       2040 
IRNRATDLDA RMHDGTTPLI LAARLAVEGM LEDLINSHAD VNAVDDLGKS ALHWAAAVNN 

      2050       2060       2070       2080       2090       2100 
VDAAVVLLKN GANKDMQNNR EETPLFLAAR EGSYETAKVL LDHFANRDIT DHMDRLPRDI 

      2110       2120       2130       2140       2150       2160 
AQERMHHDIV RLLDEYNLVR SPQLHGAPLG GTPTLSPPLC SPNGYLGSLK PGVQGKKVRK 

      2170       2180       2190       2200       2210       2220 
PSSKGLACGS KEAKDLKARR KKSQDGKGCL LDSSGMLSPV DSLESPHGYL SDVASPPLLP 

      2230       2240       2250       2260       2270       2280 
SPFQQSPSVP LNHLPGMPDT HLGIGHLNVA AKPEMAALGG GGRLAFETGP PRLSHLPVAS 

      2290       2300       2310       2320       2330       2340 
GTSTVLGSSS GGALNFTVGG STSLNGQCEW LSRLQSGMVP NQYNPLRGSV APGPLSTQAP 

      2350       2360       2370       2380       2390       2400 
SLQHGMVGPL HSSLAASALS QMMSYQGLPS TRLATQPHLV QTQQVQPQNL QMQQQNLQPA 

      2410       2420       2430       2440       2450       2460 
NIQQQQSLQP PPPPPQPHLG VSSAASGHLG RSFLSGEPSQ ADVQPLGPSS LAVHTILPQE 

      2470       2480       2490       2500       2510       2520 
SPALPTSLPS SLVPPVTAAQ FLTPPSQHSY SSPVDNTPSH QLQVPEHPFL TPSPESPDQW 

      2530       2540       2550 
SSSSPHSNVS DWSEGVSSPP TSMQSQIARI PEAFK 

P46531 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!